Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Grosso

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
The Biochemical Journal|June 8, 2001
Proteasomes are a target of the anti-tumour drug vinblastineM Piccinini, O Tazartes, C Mezzatesta, et al.
The Prostate|July 16, 2011
Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic modelTullia C Bruno, Cristin Rothwell, Joseph F Grosso, et al.
British Journal of Cancer|September 12, 2013
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trialsA L Cesne, I Judson, R Maki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution seriesF Grosso, R Sanfilippo, E Virdis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cellsJoseph F Grosso, Monica V Goldberg, Derese Getnet, et al.
Organic Letters|July 17, 2012
Coibacins A-D, antileishmanial marine cyanobacterial polyketides with intriguing biosynthetic originsMarcy J Balunas, Manuel F Grosso, Francisco A Villa, et al.
The Journal of Pathology|October 29, 2014
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progressionBrian W Simons, Nicholas M Durham, Tullia C Bruno, et al.
The Prostate|June 19, 2008
Radiotherapy augments the immune response to prostate cancer in a time-dependent mannerTimothy J Harris, Edward L Hipkiss, Scott Borzillary, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2011
Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric studyP Schöffski, M Taron, J Jimeno, et al.
Cancer Research|May 14, 2009
Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer modelSatoshi Wada, Kiyoshi Yoshimura, Edward L Hipkiss, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
The Biochemical Journal|June 8, 2001
Proteasomes are a target of the anti-tumour drug vinblastineM Piccinini, O Tazartes, C Mezzatesta, et al.
The Prostate|July 16, 2011
Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic modelTullia C Bruno, Cristin Rothwell, Joseph F Grosso, et al.
British Journal of Cancer|September 12, 2013
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trialsA L Cesne, I Judson, R Maki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution seriesF Grosso, R Sanfilippo, E Virdis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cellsJoseph F Grosso, Monica V Goldberg, Derese Getnet, et al.
Organic Letters|July 17, 2012
Coibacins A-D, antileishmanial marine cyanobacterial polyketides with intriguing biosynthetic originsMarcy J Balunas, Manuel F Grosso, Francisco A Villa, et al.
The Journal of Pathology|October 29, 2014
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progressionBrian W Simons, Nicholas M Durham, Tullia C Bruno, et al.
The Prostate|June 19, 2008
Radiotherapy augments the immune response to prostate cancer in a time-dependent mannerTimothy J Harris, Edward L Hipkiss, Scott Borzillary, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2011
Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric studyP Schöffski, M Taron, J Jimeno, et al.
Cancer Research|May 14, 2009
Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer modelSatoshi Wada, Kiyoshi Yoshimura, Edward L Hipkiss, et al.
Pageof 10